Kejia Zhang

5PUBLICATIONS
22CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 30, 2023
Hyperoside mediates protection from diabetes kidney disease by regulating ROS-ERK signaling pathway and pyroptosis.

Kejia Zhang, MiaoMiao Li, Kaiwen Yin

|May 19, 2021
Pyroptosis: A New Frontier in Kidney Diseases.

Ke-Jia Zhang, Qi Wu, Shi-Min Jiang

|May 03, 2021
Efficacy and Safety of a Combination of Shenmai Injection plus Chemotherapy for the Treatment of Lung Cancer: A Meta-Analysis.

Guo-Wei Qin, Tong-Tong Xu, Xiang-Wei Lv

|Dec 30, 2020
A Clinical Model for the Prediction of Acute Exacerbation Risk in Patients with Idiopathic Pulmonary Fibrosis.

Qi Wu, Yong Xu, Ke-Jia Zhang

|Dec 14, 2020
p53: A Key Protein That Regulates Pulmonary Fibrosis.

Qi Wu, Ke-Jia Zhang, Shi-Min Jiang

Pageof 1

Frequent Collaborators

5 joint publications

Qi Wu

5 joint publications

Yao Zhou

4 joint publications

Shi-Min Jiang

2 joint publications

Lu Fu